Antibody-Drug Conjugates: Pharmacotherapeutic Properties and Future Perspectives. [PDF]
Augusto A, Cristiano MLS, Conceição J.
europepmc +1 more source
Antibody-Drug Conjugates Beyond HER2 in Non-Small Cell Lung Cancer (NSCLC): Mechanisms, Emerging Targets, and Future Directions. [PDF]
Ismail A, Desai A, Simon GR, Boumber Y.
europepmc +1 more source
Evolution and recent advances in antibody-drug conjugate therapy for lung cancer: a comprehensive systematic review based on the Trialtrove database (inception to July 1, 2025). [PDF]
Chen Y, Zhang Y, Tian C, Li Z, Guo G.
europepmc +1 more source
Novel <i>N</i>-4-(5-Amino-7-substituted-triazolotriazinepiperazin-1-yl) Norfloxacin Analogues Exhibit Potent and Selective Anticancer Activity via Topoisomerase Inhibition, Cell-Cycle Arrest, and Apoptosis in A 431 Skin Carcinoma Cells. [PDF]
El-Saghier AM +4 more
europepmc +1 more source
Cellular strategies for repairing trapped protein-DNA complexes. [PDF]
Sideridou M +3 more
europepmc +1 more source
Sequencing antibody-drug conjugates in metastatic cancer (Review). [PDF]
Abdalla BA.
europepmc +1 more source
Pharmacological and Phytochemical Insights Into <i>Ficus benghalensis</i> (Indian Banyan): Anti-Inflammatory, Antioxidant, and Anticancer Potentials. [PDF]
Ali Z +9 more
europepmc +1 more source
Trial watch: antibody-drug conjugates in cancer therapy. [PDF]
Doffe F +6 more
europepmc +1 more source
In silico evaluation of garlic-derived organosulfur compounds as multi-target inhibitors of breast cancer biomarkers. [PDF]
Siame C, Ofori B, Paemka L, Danquah KO.
europepmc +1 more source
Topoisomerases as Targets for Novel Drug Discovery. [PDF]
Perdih A.
europepmc +1 more source

